The Complications Of Epidermolytic Ichthyosis: Skin Infections And Hyperkeratosis
Published on: February 22, 2026
Complications of Epidermolytic Ichthyosis Skin Infections and Hyperkeratosis featured image

Introduction

Imagine the thought of living with skin so fragile that even the slightest touch could cause pain. For some, a gentle hug, a warm bath, or a simple brush of clothing can lead to blistering, cracking, or peeling. This is the everyday reality for people with a rare skin condition that may have never been heard of.

It is not just about the appearance of the skin but also how it can affect things like comfort, confidence, and safety. For families and children dealing with this condition, life often revolves around managing symptoms, avoiding infections, and navigating the emotional and physical challenges that come with it. In this article, the condition will be explained thoroughly, including information on how it affects those living with it, and why understanding it matters more than you might think.

What is epidermolytic ichthyosis (EI) 

Epidermolytic ichthyosis (EI) is a rare skin condition, causing blisters filled with fluid and red skin. It is caused by mutations in the KRT1 or KRT10genes, which are crucial for generating keratin proteins.1 These proteins support the skin’s structure and barrier, mainly the upper layers of the skin. Mutations in these genes affect the regulation of these proteins, leading to skin fragility.2 The symptoms may look similar to other, less severe conditions, which is why a skin biopsy is carried out. The skin sample is put under a microscope, and if a pattern called epidermolytic hyperkeratosis is seen, it means you have EI.

Who would normally be affected? 

EI is an inherited autosomal dominant disorder. Normally, 50% of people with EI would inherit the mutated gene from a parent; therefore, the other 50% would still be born with a mutated gene, but they did not inherit it from a parent. This is known as a spontaneous genetic mutation. However, EI is a rare condition, affecting only one in 100000 to 300000 infants.3

The signs and symptoms of EI

People affected by EI have skin cells that produce a lot faster than they can shed the old cells. Due to the outer layer of the skin barrier being damaged and peeled away, the body tries to compensate by producing extra skin cells. This leads to thick, toughened, scale-like layers on the surface of the skin, often being described as cardboard-like in texture.4 The reduced moisture may cause dry eyes.

The signs and symptoms of EI are red blisters on the skin, widespread erythroderma, and skin ulcers. Infants usually have peeling skin in areas that are exposed to any friction and trauma. The condition does progress with age, the blistering decreases and eventually is replaced by dry, dark brown, grey or white macerating scales and persistent erythema. In many instances, people may develop palmoplantar keratoderma, which causes thickened skin on the palms and soles of the feet, often described as having a cardboard-like texture.3 

Complications in EI

General complications associated with EI

The complications of EI vary between the different age groups. These are:

Infants affected by EI

Newborns experience several serious complications, which include:

  • An excessive loss of water and essential fluids, which are critical for the body to function properly 
  • An imbalance of important substances, like sodium, which can interfere with bodily processes
  • Having difficulty regulating their body temperature, which may lead to hyperthermia or hypothermia
  • An increased risk of infections, both on the skin and potentially throughout the body4

Adults affected by EI

Adults may have complications such as:

  • Impaired sweating due to thickened skin
  • Fragile skin that cracks easily, resulting in frequent infections
  • Scratching of the skin
  • Hearing issues due to the buildup of skin scales in the ear canals
  • Thin and fragile hair due to clogged hair follicles on the scalp
  • Thickened skin on the palms and soles, which may affect mobility and cause discomfort4

Two major complications 

The major complications of EI in all age groups are:

The importance of understanding the complications of EI

Understanding the complications is very important as it can detect the condition at an early stage; therefore, early treatment and management can prevent the condition from worsening into serious conditions such as sepsis.5 Additionally, people with EI are more prone to skin fragility throughout their life; therefore, it is crucial to educate people to minimise physical trauma.

Skin infections in EI

Understanding the condition

People with EI have a damaged skin barrier, so they are more vulnerable to different types of skin infections. The infection may present as warm, tender areas of the skin, and there may be more discharge on the affected site. The impaired skin barrier causes a buildup of thick, moist scales, which is an ideal environment for organisms like bacteria and fungi to become trapped inside and grow. Additionally, the cracks and fissures on the skin enable germs to enter the body, increasing further infection.6 

Types of infections

Bacterial infections

Colonisation occurs when bacteria live on the skin for long periods of time without causing an infection. This may lead to increased skin irritation as well as areas of moisture, maceration and a slight odour. People with EI are more prone to colonisation by Staphylococcus aureus, which is a common bacterium associated with the skin.6 The colonisation may not cause immediate harm to the skin, but has a higher chance of an active infection developing when the skin barrier is impaired.

Fungal infections

People with ichthyosis have an impaired skin barrier; therefore, fungal infections may evade the immune system by hiding in areas of the thickened skin scale. There have been many cases of ichthyosis vulgaris, lamellar ichthyosis, and Keratitis-Ichthyosis-Deafness (KID) syndrome, which have been reported as a result of the thickened skin, leading to an increased risk of infection.6

Clinical signs of infection

The infection causes raised white bumps, raw, weeping areas, as well as patches of the skin covered in yellow-toned crust. When the skin becomes itchy or a person develops a fever, it indicates that the infection is active and spreading.6 The immune system reacts due to the body's natural defence being targeted, requiring immediate medical attention if it is the case.

Diagnosis

EI skin infections can be diagnosed in many ways, which include tests such as clinical examination, histopathological analysis and laboratory findings. Genetic testing also confirms the condition by identifying the site of the genetic mutations.6

Treatment and management strategies

There is currently no cure for EI; however, there are treatments which focus on managing the symptoms, which are dependent on the age, sex, severity of the disease and the location of the affected skin. 

Some management strategies for EI include:

  • Emollients such as glycerol, petrolatum, and other lipid-based agents are commonly used to maintain skin moisture
  • Antiseptics like antibacterial soaps, chlorhexidine, or sodium hypochlorite baths are used to reduce the risk of infection7
  • Oral antibiotic treatments for infections

Future research on treatment 

There is a study that was the first to report the use of Vunakizumab, which is a self-developed drug from China, that used an anti-IL-17A monoclonal antibody for the treatment of EI. The case involved a four-year-old child with EI due to KRT1 gene mutations. The child had symptoms since birth, eventually developing hyperkeratosis. Following a three-month course of the new drug, the child had significant improvement, and the inflammatory markers were surprisingly normal, making it a potential treatment.8

Another study used cultured epidermal autografts, which are lab-grown skin cells, which were able to repair damaged skin. Genetic testing was able to confirm that the lab-grown skin was made up of healthy skin cells, which had naturally corrected the genetic issue and had the same mechanisms as a healthy cell. This lab-grown skin was placed on the affected area of people who showed significant improvement within four weeks.9

FAQs

What is epidermolytic ichthyosis (EI)?

EI is a rare genetic skin condition present from birth that causes fragile skin, blistering, and thick, scaly patches over time.

What causes EI?

It is caused by mutations in the KRT1 or KRT10 genes, which are important for building strong skin. These mutations make the skin less able to protect itself.

Is EI contagious?

EI is not contagious as it is a genetic condition, meaning it is inherited or caused by a mutation during development.

Who can be affected by EI?

EI can affect anyone, regardless of gender or ethnicity. It affects about 1 in 100,000 to 300,000 newborns.

What are the main symptoms?

Symptoms include red skin, blisters at birth, and thick, dry, scaly skin as the child grows. The skin may be painful, itchy, and prone to cracking or infection.

Summary

Epidermolytic Ichthyosis (EI) is a rare genetic skin disorder which causes fragile, blistered skin. This condition is caused by mutations in the KRT1 or KRT10 genes, affecting the skin barrier. Although there is no cure yet, there are treatments which help manage symptoms, such as moisturisers, antiseptics, antibiotics, and special creams. New therapies, including biologic drugs and lab-grown skin, have also shown promising results. Early diagnosis and understanding of complications like infections and thickened skin can help improve care and quality of life.

References 

  1. Tanahashi K, Kono M, Yoshikawa T, Suzuki Y, Inoie M, Kuwatsuka Y, et al. Treating epidermolytic ichthyosis and ichthyosis with confetti with epidermal autografts cultured from revertant skin. Br J Dermatol. 2024 Aug 14;191(3):397–404. Available from: https://academic.oup.com/bjd/article/191/3/397/7671063 .
  2. Eskin-Schwartz M, Drozhdina M, Sarig O, Gat A, Jackman T, Isakov O, et al. Epidermolytic ichthyosis sine epidermolysis. Am J Dermatopathol. 2017 Jun;39(6):440–4.Available from: https://journals.lww.com/00000372-201706000-00004. 
  3. DermNet® [Internet]. 2023. Epidermolytic ichthyosis. Available from: https://dermnetnz.org/topics/epidermolytic-ichthyosis
  4. Foundation for Ichthyosis & Related Skin Types (FIRST). Epidermolytic Ichthyosis [Internet]. Available from: https://www.firstskinfoundation.org/types-of-ichthyosis/epidermolytic-ichthyosis 
  5. Rice AS, Crane JS. Epidermolytic hyperkeratosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: http://www.ncbi.nlm.nih.gov/books/NBK544323/
  6. Browning JC. Skin Infection in Ichthyosis [Internet]. Foundation for Ichthyosis & Related Skin Types (FIRST); 2022 Aug 2. Available from: https://www.firstskinfoundation.org/skin-infection-in-ichthyosis 
  7. Peter Rout D, Nair A, Gupta A, Kumar P. Epidermolytic hyperkeratosis: clinical update. Clin Cosmet Investig Dermatol [Internet]. 2019 May 8;12:333–44. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512611/
  8. Cheng W, Pan C, Sun Z, Sun P, Li J, Yao Z, et al. First successful treatment of epidermolytic ichthyosis with Vunakizumab: a case report. Front Immunol [Internet]. 2025 May 16;16:1574255. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12122345/
  9. Seervai RNH, Wiggins CJ, Gordon H, Oakley A. Epidermolytic ichthyosis. DermNet New Zealand. 2020 Jul. Available from: https://dermnetnz.org/topics/ep

Share

Samia Khanom

arrow-right